MedTrace Logo

Serum Metabolics-based Method for Diagnosing Bile Acid Diarrhoea

NCT06548009 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-05-01

No results posted yet for this study

Summary

Bile acid diarrhoea (BAD) is a common yet under-diagnosed and under-recognised disease. The primary symptoms are watery diarrhoea with high frequency of unpredictable bowel movements,urgency and faecal incontinence making BAD a debilitating condition. One of the challenges of BAD is the lack of a readily available and accurate diagnostic test.

The aim of this study is to validate a BAD diagnostic score (BDS) based on metabolomics.

Conditions

  • Bile Acid Malabsorption
  • Bile Acid Diarrhea

Interventions

DIAGNOSTIC_TEST

Metabolomics and other blood samples

Blood samples taken with the objective of identifying a diagnostic test

Sponsors & Collaborators

  • University Hospital, Gentofte, Copenhagen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-31
Primary Completion
2025-04-15
Completion
2025-04-15

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06548009 on ClinicalTrials.gov